Cayman Chemical Company, Incorporated
Patent Owner
Stats
- 22 US PATENTS IN FORCE
- 2 US APPLICATIONS PENDING
- Mar 13, 2018 most recent publication
Details
- 22 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 102 Total Citation Count
- Feb 01, 2001 Earliest Filing
- 14 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2016/0158,413 METHODS, SYSTEMS, AND COMPOSITIONS FOR PROMOTING BONE GROWTHJul 18, 14Jun 09, 16[A61L]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9708287 Chiral compounds, compositions, products and methods employing sameOct 01, 15Jul 18, 17[A61K, C07H, C07D, A61Q]
9688627 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditionsMar 14, 14Jun 27, 17[C07D]
9487478 Difluorolactam compounds as EP4 receptor-selective agonists for use in the treatment of EP4-mediated diseases and conditionsOct 01, 15Nov 08, 16[A61K, C07D]
9440919 Difluorolactam compositions for EP4-mediated osteo related diseases and conditionsJul 19, 13Sep 13, 16[A61K, C07D]
9180080 Chiral compounds, compositions, products and methods employing sameJan 04, 13Nov 10, 15[A61K, C07H, C07D, A61Q]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2015/0322,107 FLUORESCENT MOLECULAR PROBES FOR USE IN ASSAYS THAT MEASURE TEST COMPOUND COMPETITIVE BINDING WITH SAM-UTILIZING PROTEINSAbandonedJul 17, 15Nov 12, 15[C07H, G01N]
2015/0323,542 FLUORESCENT MOLECULAR PROBES FOR USE IN ASSAYS THAT MEASURE TEST COMPOUND COMPETITIVE BINDING WITH SAM-UTILIZING PROTEINSAbandonedJul 17, 15Nov 12, 15[C07D, G01N]
2015/0315,114 Methods of Synthesizing a Prostacyclin AnalogAbandonedDec 06, 13Nov 05, 15[C07F, C07D, C07C]
2013/0224,137 SKIN LIGHTENING COMPOSITIONSAbandonedJan 04, 13Aug 29, 13[A61K, C07H, C07D, C07C, A61Q]
8450326 Multiheteroaryl compounds as inhibitors of H-PGDS and their use for treating prostaglandin D2 mediated diseasesWithdrawnSep 22, 09May 28, 13[A61K, C07D]
2013/0079,375 MULTIHETEROARYL COMPOUNDS AS INHIBITORS OF H-PGDS AND THEIR USE FOR TREATING PROSTAGLANDIN D2 MEDIATED DISEASESAbandonedNov 01, 12Mar 28, 13[A61K, C07D]
2012/0021,437 TETRANOR-PGDM/PGJM SPECIFIC IMMUNOGENS, ANTIBODIES, TRACERS, ASSAY KITS AND METHODS FOR MAKING SAMEAbandonedJun 14, 11Jan 26, 12[C12N, C07D, G01N, C07K]
2011/0311,990 TETRANOR-PGEM/PGAM SPECIFIC IMMUNOGENS, ANTIBODIES, TRACERS, ASSAY KITS AND METHODS FOR MAKING SAMEAbandonedJun 14, 11Dec 22, 11[C12N, C07C, G01N, C07K]
7674921 analogs and their use in the treatment of glaucoma and intraocular hypertensionExpiredFeb 25, 08Mar 09, 10[C07D]
2009/0124,695 PROSTAGLANDIN E1 AND E2 ANALOGS FOR THE TREATMENT OF VARIOUS MEDICAL CONDITIONSAbandonedNov 14, 08May 14, 09[A61K, C12N, C07C]
2009/0088,473 METHOD FOR SCREENING OF PROSTAGLANDIN COMPOUNDS COMPRISING AN OPTIMAL FORMULATION FOR THE ENHANCEMENT OF HAIR GROWTH AND THE STIMULATION OF FOLLICULAR ANAGEN AND FORMULATIONS RESULTING THEREFROMAbandonedSep 26, 08Apr 02, 09[A61K, C12Q]
2007/0050,194 Systems and methods for providing open access to scientific informationAbandonedAug 25, 05Mar 01, 07[G06Q]
2006/0264,353 Prostaglandin f2alpha analogs and their use in combination with antimicrobial proteins for the treatment of glaucoma and intraocular hypertensionAbandonedMar 21, 03Nov 23, 06[A61K]
2001/0046,982 Internal 1, 15-lactones of fluprostenol and related prostaglandin F2a analogs and their use in the treatment of glaucoma and intraocular hypertensionAbandonedFeb 01, 01Nov 29, 01[A61K, C07D]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.